Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 11,499 | 14,122 | 5,541 | 0 |
| Operating Income | -11,499 | -14,122 | -5,541 | N/A |
| Other Income | 185 | 247 | 378 | 0 |
| Pre-tax Income | -11,314 | -13,875 | -5,163 | 0 |
| Net Income Continuous | -11,314 | -13,875 | -5,163 | N/A |
| Minority Interests | -1,456 | -5,253 | -190 | N/A |
| Net Income | $-9,858 | $-8,622 | $-4,973 | $N/A |
| EPS Basic Total Ops | -0.50 | -0.44 | -0.27 | N/A |
| EPS Basic Continuous Ops | -0.57 | -0.71 | -0.28 | N/A |
| EPS Diluted Total Ops | -0.50 | -0.44 | -0.27 | N/A |
| EPS Diluted Continuous Ops | -0.57 | -0.71 | -0.28 | N/A |
| EBITDA(a) | $-11,484 | $-14,106 | $-5,525 | $N/A |